当前位置: 首页 > 详情页

Security analysis of implanting drug-eluling stents for unprotected left main coronary artery disease patients with chronic kidney disease

文献详情

资源类型:

收录情况: ◇ 统计源期刊 ◇ 北大核心 ◇ CSCD-C ◇ 中华系列

机构: [1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China
出处:
ISSN:

关键词: Chronic kidney disease mlectecl left main artery Coronary artery disease Drug-eluting stent

摘要:
Objective To study the clinical characteristics and prognosis of unprotected left main (Ul-M) coronary artery disease patients with chronic kidney disease after drug-eluting stents ( DKS) implantation. Methods 267 UI.M coronary artery disease patients who has implanted DKS were included in the study from January 2005 to March 2010. Patients were divided into two groups according to their estimated glomerular filtration rate ( EGFR ) : EGFR <60 ml • min-1 • 1.73 min-2(77 patients), and eCFR≥ 60 ml • min-1 • 1.73 min-2( 190 patients) . The clinical parameters and prognosis of ULM patients treated with DKS in different EGFR groups were retrospectively compared. Results In higher EGFR group, left ventricular ejection fraction (LVRF) and morbidity of coronary ostial lesions were higher than the other group. Cerebrovascular diseases ( 13.0% vs 5.3% ) , chronic total occlusion (CTO, 28.6% vs 12.1%), hypertension (70. 1 % vs 53.2% ) were more common in lower EGFR patients ( all P < 0.05 ) . Total mortality and c ardiac mortality were higher in EGFR <60 ml • min-1 • 1.73 m-2 group ( P =0.016,0.006, respectively). Low EGFR level was an independent risk factor after adjusting multiple factors. Conclusion For the lil.M disease patients with reduction in kidney function (EGFR <60 ml • min-1 • 1.73 m-2) , DES should be selected with a careful study considering its increasing risk of death. Chronic renal insufficiency is a risk factor and may predict poor prognosis for patients with UI.M after DKS implantation.

语种:
第一作者:
第一作者机构: [1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China
推荐引用方式(GB/T 7714):

相关文献

[1]Drug-Eluting Balloon Versus Bare-Mental Stent and Drug-Eluting Stent for De Novo Coronary Artery Disease: a Systematic Review and Meta-Analysis [2]Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials [3]Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Diabetic Patients With Multivessel and/or Left Main Coronary Artery Disease: A Meta-Analysis [4]Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis. [5]Long term outcomes of drug-eluting stent versus coronary artery bypass grafting for left main coronary artery disease: a meta-analysis [6]Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting for diabetic patients with multivessel and/or left main disease: a meta-analysis [7]Associated factors with repeat coronary angioplasty during the drug eluting stent era: a high volume center investigation [8]Effect of Remote Ischemic Preconditioning in the Elderly Patients With Coronary Artery Disease With Diabetes Mellitus Undergoing Elective Drug-Eluting Stent Implantation [9]Comparison of drug eluting stent implantation with coronary artery bypass surgery in the treatment of patients with chronic total occlusion and multiple vessel disease [10]Comparison of repeated drug eluting stent for treatment of early and late in-stent restenosis after drug eluting stent implantation

资源点击量:18261 今日访问量:0 总访问量:1004 更新日期:2025-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院